Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Liquidia Technologies Inc
LT4Current price
11.36 EUR
0 EUR (0.00%)
Last closed
11.76 USD
Company
www.liquidia.com
ISIN
US53635D2027
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
933 541 696 USD
Yield for 12 month
-8.24 %
1Y
3Y
5Y
10Y
15Y
LT4
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina. Address: 419 Davis Drive, Morrisville, NC, United States, 27560
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
25.44 USDP/E ratio
–Dividend Yield
–Current Year
+17 488 000 USD
Last Year
+15 935 000 USD
Current Quarter
+4 448 000 USD
Last Quarter
+3 659 000 USD
Current Year
+14 600 000 USD
Last Year
+13 076 000 USD
Current Quarter
+2 883 000 USD
Last Quarter
+2 166 000 USD
Key Figures LT4
1 year
3 years
5 years
10 years
EBITDA
-95 836 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-40.69 %
PEG Ratio
–
Return On Equity TTM
-181.73 %
Wall Street Target Price
25.44 USD
Revenue TTM
14 840 000 USD
Book Value
0.69 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-23.50 %
Dividend Yield
–
Gross Profit TTM
13 076 000 USD
Earnings per share
-1.64 USD
Diluted Eps TTM
-1.64 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics LT4
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History LT4
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation LT4
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
46.88
Price Sales TTM
62.91
Enterprise Value EBITDA
-9.43
Price Book MRQ
8.45
Financials LT4
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators LT4
For 52 weeks
7.76 USD
16.99 USD
50 Day MA
10.90 USD
Shares Short Prior Month
10 262 877
200 Day MA
12.05 USD
Short Ratio
12.26
Shares Short
10 562 301
Short Percent
18.88 %
BeatStart